Inventor profile of:

Michael K. Skinner

City:

Pullman, Washington

Country:

United States

Published Applications:

15

Last publication date:

2025-03-06

Top Assignees for applications by Michael K. Skinner

The entities that hold a legal rights for patent applications filed by inventor Skinner Michael K.:

Recent patent applications by Skinner Michael K.

Michael K. Skinner from Pullman, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-03-06
US20250079015A1
Physics

DNA METHYLATION BIOMARKERS FOR PRETERM BIRTH

#2 | 2025-01-30
US20250034642A1
Chemistry; metallurgy

DNA METHYLATION BIOMARKERS FOR RHEUMATOID ARTHRITIS

#3 | 2022-11-17
US20220364176A1
Chemistry; metallurgy

HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE

#4 | 2022-09-01
US20220275439A1
Chemistry; metallurgy

METHODS AND KITS FOR INFERTILITY DIAGNOSTICS

#5 | 2022-06-09
US20220178944A1
Physics

METHODS FOR IDENTIFYING DIFFERENTIAL HISTONE RETENTION FOR EPIGENETIC ALTERATIONS IN GERMLINE DNA OF ANIMALS

#6 | 2021-07-01
US20210202033A1
Physics

NOVEL MACHINE LEARNING APPROACH FOR THE IDENTIFICATION OF GENOMIC FEATURES ASSOCIATED WITH EPIGENETIC CONTROL REGIONS AND TRANSGENERATIONAL INHERITANCE OF EPIMUTATIONS

#7 | 2021-03-11
US20210071253A1
Chemistry; metallurgy

HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE

#8 | 2019-06-06
US20190169691A1
Chemistry; metallurgy

HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE

#9 | 2017-09-07
US20170253927A1
Chemistry; metallurgy

HERITABLE EPIGENETIC MODIFICATIONS AS MARKERS OF CHEMOTHERAPY EXPOSURE

#10 | 2017-05-11
US20170132362A1
Physics

NOVEL MACHINE LEARNING APPROACH FOR THE IDENTIFICATION OF GENOMIC FEATURES ASSOCIATED WITH EPIGENETIC CONTROL REGIONS AND TRANSGENERATIONAL INHERITANCE OF EPIMUTATIONS

#11 | 2013-08-29
US20130226468A1
Physics

Genomic features associated with epigenetic control regions and transgenerational inheritance of epimutations

#12 | 2011-02-24
US20110045102A1
Human necessities

Cancer chemotherapy compositions comprising PI3K pathway modulators and triptolide

#13 | 2008-09-25
US20080233089A1
Human necessities

Modified cells expressing a protein that modulates activity of bHLH proteins, and uses thereof

#14 | 2007-04-26
US20070092585A1
Human necessities

Cancer chemotherapy compositions comprising PI3K pathways modulators and triptolide

#15 | 2006-12-21
US20060286585A1
Physics

Methods for diagnosing epigenetic, transgenerational effects of environmental toxicants on mammalian germ-lines and treating associated diseases

InventorID:

418023 ⎘